We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+11.56%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$8.44B
AUM Growth
+$1.09B
Cap. Flow
+$577M
Cap. Flow %
6.84%
Top 10 Hldgs %
15.63%
Holding
838
New
218
Increased
181
Reduced
162
Closed
220

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$123M
2
HES
Hess
HES
+$115M
3
ATVI
Activision Blizzard
ATVI
+$108M
4
COR icon
Cencora
COR
+$106M
5
MSFT icon
Microsoft
MSFT
+$101M

Top Sells

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$108M
2
ADI icon
Analog Devices
ADI
+$105M
3
KEYS icon
Keysight
KEYS
+$101M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$82.2M
5
BKNG icon
Booking.com
BKNG
+$58.2M

Sector Composition

Rank Sector Weight
1 Healthcare 37.55%
2 Technology 28%
3 Industrials 9.43%
4 Energy 7.74%
5 Consumer Discretionary 5.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLRX icon
301
Pliant Therapeutics
PLRX
$64.4M
$4.67M 0.06%
+257,498
New +$6.1M
FYBR
302
DELISTED
Frontier Communications
FYBR
$4.6M 0.05%
+246,821
New +$4.63M
PMVP icon
303
PMV Pharmaceuticals
PMVP
$59.2M
$4.59M 0.05%
733,735
+557,847
+317% +$2.92M
WW
304
DELISTED
WW International
WW
$4.58M 0.05%
682,181
+652,769
+2,219% +$4.63M
BLE
305
DELISTED
BlackRock Municipal Income Trust II
BLE
$4.56M 0.05%
438,490
-310,192
-41% -$3.2M
EXAI
306
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$4.54M 0.05%
767,349
+144,691
+23% +$887K
SPRY icon
307
ARS Pharmaceuticals
SPRY
$509M
$4.49M 0.05%
670,087
+70,087
+12% +$468K
TFX icon
308
Teleflex
TFX
$6.05B
$4.47M 0.05%
18,453
-13,738
-43% -$3.44M
NVRO
309
DELISTED
NEVRO CORP.
NVRO
$4.38M 0.05%
172,478
-196,128
-53% -$5.66M
PCRX icon
310
Pacira BioSciences
PCRX
$1.04B
$4.34M 0.05%
108,376
+5
+0% +$207
CTR
311
DELISTED
ClearBridge MLP and Midstream Total Return Fund Inc.
CTR
$4.32M 0.05%
136,197
+34,334
+34% +$1.02M
DYN icon
312
Dyne Therapeutics
DYN
$4.7B
$4.3M 0.05%
+382,576
New +$4.51M
SVV icon
313
Savers
SVV
$1.58B
$4.27M 0.05%
+180,000
New +$4.19M
CNTA
314
DELISTED
Centessa Pharmaceuticals
CNTA
$4.26M 0.05%
687,763
-48,230
-7% -$229K
EVCM icon
315
EverCommerce
EVCM
$2.18B
$4.22M 0.05%
+356,415
New +$4.16M
CLDI icon
316
Calidi Biotherapeutics
CLDI
$1.98M
$4.2M 0.05%
208
– –
IDYA icon
317
IDEAYA Biosciences
IDYA
$3.42B
$4.16M 0.05%
+177,024
New +$3.64M
ARYE
318
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
$4.14M 0.05%
400,000
– –
GRVY
319
GRAVITY
GRVY
$430M
$4.14M 0.05%
58,938
– –
SEM
320
DELISTED
Select Medical
SEM
$4.13M 0.05%
+240,304
New +$3.72M
JSPR icon
321
Jasper Therapeutics
JSPR
$21M
$4.11M 0.05%
300,000
– –
BERY
322
DELISTED
Berry Global Group, Inc.
BERY
$4.1M 0.05%
+69,379
New +$3.79M
ELF icon
323
e.l.f. Beauty
ELF
$4.89B
$4.09M 0.05%
35,821
-79,880
-69% -$7.69M
KMF
324
DELISTED
Kayne Anderson NextGen Energy & Infrastructure, Inc.
KMF
$4.09M 0.05%
576,228
– –
KNSA icon
325
Kiniksa Pharmaceuticals
KNSA
$5.8B
$4.08M 0.05%
+290,001
New +$3.88M
11 12
13
14 15

Similar funds

PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
TCIIS
TIAA-CREF Individual & Institutional Services New York $26B AUM
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return

Woodline Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Woodline Partners held 838 positions worth $8.44B, up 15% from $7.35B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Woodline Partners deployed $577M of net new capital in Q2 2023, opening 218 new positions and adding to 181 existing holdings. Its largest new stake was Hess: 837,083 shares worth $114M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 35% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Keysight, an estimated $101M trimmed.

  • Woodline Partners's largest Q2 2023 buy was Hess: 837,083 shares worth $114M.
  • Woodline Partners added most to Johnson & Johnson in Q2 2023, an estimated $123M increase.
  • Woodline Partners's biggest Q2 2023 reduction was Keysight, cutting an estimated $101M.
  • Woodline Partners fully exited Baxter International in Q2 2023, selling an estimated $108M.
  • Woodline Partners's ten largest holdings make up 16% of its $8.44B portfolio in Q2 2023.
  • Woodline Partners opened 218 new positions and closed 220 in Q2 2023.
  • Woodline Partners's portfolio value rose 15% quarter-over-quarter to $8.44B.

Based on Woodline Partners's 13F filing for Q2 2023, filed 14 Aug 2023.